Your browser doesn't support javascript.
loading
Adjuvant zoledronic acid reduces fractures in breast cancer patients; an AZURE (BIG 01/04) study.
Wilson, C; Bell, R; Hinsley, S; Marshall, H; Brown, J; Cameron, D; Dodwell, D; Coleman, R.
Afiliación
  • Wilson C; Academic Unit of Clinical Oncology, Weston Park Hospital, University of Sheffield, Sheffield, UK. Electronic address: c.wilson@sheffield.ac.uk.
  • Bell R; Deakin University, Geelong, Australia.
  • Hinsley S; Clinical Trials Research Unit, Leeds, UK.
  • Marshall H; Clinical Trials Research Unit, Leeds, UK.
  • Brown J; Academic Unit of Clinical Oncology, Weston Park Hospital, University of Sheffield, Sheffield, UK.
  • Cameron D; Cancer Research UK Edinburgh Centre, Western General Hospital, University of Edinburgh, UK.
  • Dodwell D; Institute of Oncology, Bexley Wing, St James Hospital, Leeds, UK.
  • Coleman R; Academic Unit of Clinical Oncology, Weston Park Hospital, University of Sheffield, Sheffield, UK.
Eur J Cancer ; 94: 70-78, 2018 05.
Article en En | MEDLINE | ID: mdl-29544162
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Fracturas Óseas / Conservadores de la Densidad Ósea / Ácido Zoledrónico Tipo de estudio: Clinical_trials / Incidence_studies / Prognostic_studies Idioma: En Revista: Eur J Cancer Año: 2018 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Fracturas Óseas / Conservadores de la Densidad Ósea / Ácido Zoledrónico Tipo de estudio: Clinical_trials / Incidence_studies / Prognostic_studies Idioma: En Revista: Eur J Cancer Año: 2018 Tipo del documento: Article